Evaluación bioquímica del estado nutricional en un grupo de puérperas. Estudio preliminar / Biochemical evaluation of nutritional status in a group of puerperal women. Preliminary study

Se determinaron los niveles de proteína transportadora de vitamina A, transtirretina (prealbúmina), transferrina, inmunoglobulina A, fracción C3 de complemento en suero y de inmunoglobulina A total en saliva, en un grupo de 109 mujeres durante los primeros días post-parto. Las muestras de sangre y saliva no estimulada de las pacientes en ayunas se mantuvieron a -20 ºC hasta ser analizadas por inmunodifusión radial en placas de agarosa. Los resultados (media ± DE), expresados como porcentaje de las proteínas totales, fueron: 0,06 ± 0,02; 0,24 ± 0,06; 6,36 ± 1,19; 2,70 ± 0,47 y 3,76 ± 1,17 para proteína transportadora de vitamina A, transtirretina, transferrina, C3 e IgA sérica respectivamente, mientras que los de IgA en saliva fueron de 14,3 ± 10,3 mg/dL. Los valores de proteína transportadora de vitamina A y transtirretina fueron significativamente menores a los de referencia, lo que sugeriría un posible estado nutricional materno deteriorado que no se reflejó en el peso de los recién nacidos

Efecto de una vacuna antisarampión como modelo de infección viral leve sobre la transferrina medida funcional e inmunoquímicamente / Effect of measles vaccine as a mild viral infection model on serum transferrin

Con el objeto de validar la medición de transferrina sérica como indicador de nutrición calórico-proteica y de estado nutricional de hierro durante la infección viral leve, se estudiaron 47 lactantes, sanos y eutróficos de 12 meses de edad, antes y después de 9 y 30 días de haber recibido una vacuna antisarampión de rutina. La proteína fue determinada tanto en relación a su capacidad de unir hierro (TIBC), como a su calidad inmunoquímica (RID). Al día 8 ñ 2, el 81% de los niños presentaron un alza febril de 1 a 3 días de duración. En este estudio, ambos métodos mostraron una correlación positiva baja, lo que no permitiría a su conversión (r= 0,63 y 0.69 al día 0, 9 y 30 respectivamente). Este modelo de infección viral, la capacidad funcional de la proteína (TIBC) permaneció inalterada, por lo cual se le consideraría como un índice válido en la evaluación de la nutrición de hierro en esta condición. Debido a que la transferrina (TFN) disminuyó significativamente al día 9 post-vacunación (p< 0,01) en el grupo febril, su interpretación como indicador de estado nutricional debe considerar datos clínicos adicionales

[Anemia in malignant tumor diseases. V. The relation of tumor-induced hypotransferrinemia and the degree of anemia]. / Die Anämie bei malignen Tumorerkrankungen. V. Die Beziehung zwischen der tumorbedingten Hypotransferrinämie und dem Grad der Anämie.

Transferrin is a growth factor in malignancy. In this function, transferrin is taken up into the proliferating malignant cell. The tumor-induced loss of circulating transferrin results in a hypotransferrinemia which correlates with tumor mass and proliferation rate. The cellular uptake of iron into the erythropoietic precursors depends on the presence of iron-saturated transferrin. Thus, iron utilization for the hemoglobin synthesis correlates with the transferrin concentration in blood. In 256 patients with malignancies of different histological types and different tumor extension a strong correlation was found between the degree of tumor-induced hypotransferrinemia and anemia. This correlation between transferrin concentration and hemoglobin concentration could be demonstrated in the different histological tumor entities. Tumor progression was accompanied by a progressive fall in transferrin concentration and hemoglobin concentration. By contrast, tumor remission achieved by an effective antineoplastic therapy resulted in an improvement of hypotransferrinemia and anemia. These variations in the two parameters were found to be strongly correlated. We conclude from our data that tumor-induced loss of transferrin is one of the most important factors responsible for the development of anemia in malignancy.

Iron nutrition in childhood malignancy.

Status of iron nutrition along with demographic, anthropometric, dietary, and biochemical parameters were recorded in 98 pediatric cancer patients at the time of referral. Dietary intake in each patient was analyzed for calories, protein, and iron. Blood specimens were analyzed for hemoglobin (Hgb), hematocrit (Hct), iron, total iron-binding capacity (TIBC), transferrin, and ferritin. Dietary intake measures were assessed according to each subject's Recommended Dietary Allowance (RDA). The results were compared among three diagnostic groups, namely, benign, solid tumor, and hematopoietic. The nutrient lowest in intake was iron. The overall measures revealed significant differences between the benign and hematopoietic groups in all parameters except TIBC and transferrin. A correlation coefficient of 0.55 (p less than 10(-5) between transferrin and TIBC was generated in our patients. Significant differences were noted for ferritin in the acute lymphocytic leukemia (p = 0.0001) and lymphoma (p = 0.0007) groups when compared with the benign group. A correlation coefficient of 0.55 (p less than 10(-5) was generated in our patients. A 3-month follow-up assessment was conducted in order to document the effects of therapy. Tumor response and progression was compared to changes in ferritin levels from baseline to follow-up. Our results support the literature, that ferritin is a sensitive tumor marker in various malignancies.

TSF, RBP and TBPA as nutritional indices in surgical patients with gynecological cancer.

The Authors investigated the usefulness of some biochemical markers of visceral protein synthesis (TSF, TBPA and RBP) in 24 patients affected with gynecological cancer and treated with Total Parenteral Nutrition in the perioperative period. The absence of an improving TSF and TBPA is related to increased morbidity and mortality.

[Indices of iron metabolism in newborn infants and children in the 1st year of life]. / Pokazateli obmena zheleza u novorozhdennykh i detei pervogo goda zhizni.

Biochemical parameters of iron metabolism have been examined in 36 newborns born to mothers with normal iron metabolism and in 58 healthy children aged under one year. Normal values of serum iron, serum transferrin and ferritin, and of transferrin saturation with iron in newborns and infants aged under one are presented.

Plasma transferrin levels in abnormal endocrine states. I. The changes in hypophysial diseases before and after treatment.

The concentrations of plasma transferrin (Tf), which has been described possessing growth promoting activity in vitro, were determined in patients with hypophysial diseases before and after treatment. Plasma Tf levels in 74 healthy subjects were 269 +/- 3 (mean +/- SE) mg/dl. In 11 patients with active acromegaly, they were elevated to 353 +/- 11 mg/dl (P less than 0.001), while they were reduced to 168 +/- 14 mg/dl in 8 patients with hypopituitarism (P less than 0.001). They were normalized after appropriate treatment. These data indicate that plasma Tf varies according to endocrine status in relation to that of plasma somatomedin-C, and therefore its measurement may be useful clinically for the evaluation of the status of growth factors. However, the values should be assessed carefully in cases with proper Tf abnormalities, such as hematological, hepatic or renal disorders.

A screening test for detecting iron overload in population studies.

A simple, robust, inexpensive and reasonably accurate screening test, which involves colorimetric assessment of the unsaturated iron-binding capacity, was used to detect significant degrees of iron overload in a field setting. It was used in a survey of 152 men aged over 40 years who had previously been identified as having serum ferritin values above 400 micrograms/l and who were therefore potentially homozygous carriers of the HLA-linked iron-loading gene responsible for the clinical disorder idiopathic haemochromatosis (IHC). Such individuals almost always have a raised transferrin saturation and the screening test was compared with a standard method of measurement. The screening test accurately identified 7 out of 10 subjects with transferrin saturations above 62%. It also accurately identified 137 out of 142 subjects with saturation below 62%. There were 5 false-positive results; in all these subjects saturations were at the upper limit of normal or marginally raised. The test thus had a sensitivity of 77%, a specificity of 97%, an accuracy of 95% and a positive predictive accuracy of 67%. The test successfully identified a subgroup of subjects with serum ferritin values above 400 micrograms/l who appeared to have more severe degrees of iron overload. The screening test, which requires only 200 microliter serum and costs only 6.2 c, should not only be of potential value in identifying subjects at risk of developing the clinical manifestations of IHC but may prove even more useful in defining the prevalence of significant iron overload in the rural black population of South Africa.

Iron deficiency in adolescent female dancers.

The iron balance of 25 adolescent dancers and 23 control females of the same age were studied. The concentrations of fasting blood haemoglobin, serum iron, serum transferrin and serum ferritin were determined. Iron supplementation (ferrous sulphate corresponding to 100 mg of elemental iron per day) was instigated if body iron stores were low (serum ferritin less than 30 micrograms.l-1). Blood samples were drawn again after ten weeks. Low haemoglobin concentration (blood haemoglobin less than 125 g.l-1) was more prevalent among dancers than among control subjects. Reduced iron stores as well as completely absent iron stores (serum ferritin concentration less than 12 micrograms.l-1) were equally common in both groups (25% of the subjects). Iron supplementation reduced the number of anaemic girls from 16 to 4 and the highly significant difference in haemoglobin level between the treated and untreated groups disappeared. Ten weeks of iron therapy was not, however, long enough to increase iron stores.

Iron deficiency in female athletes: its prevalence and impact on performance.

The prevalence of iron deficiency and its impact on performance have not been adequately investigated in non-endurance athletes. This study evaluated these factors in 100 female intercollegiate athletes in various sports, and in 66 non-athletes. All subjects had determinations of hemoglobin, ferritin, and transferrin saturation. Athletes reported on diet, menses, and symptoms. Athletes and coaches described mood and performance. Iron-deficient athletes were treated with iron; others received placebo. The same data were collected at season's end. Initially 31/100 (31%) athletes had iron deficiency (ferritin less than 12 ng.ml-1; transferrin saturation less than 16%, or both) compared to 30/66 (45.5%) controls (not statistically significant). Compared to normal athletes, iron-deficient athletes did not have more symptoms of iron deficiency or differences in mood state, but they considered their performance to be worse (P less than 0.05). Their total iron intakes were similar, as were menstrual blood losses. At re-evaluation, 7/45 (15.6%) initially normal athletes were iron-deficient; 14/22 (63.6%) initially iron-deficient athletes were normal. Athletes receiving an iron supplement and their coaches did not report a greater improvement in performance or mood than athletes receiving a placebo. Female college athletes frequently had iron deficiency that could be successfully treated during the season, while some untreated normal athletes became iron-deficient. Iron deficiency and its treatment had no significant impact on symptoms or mood, but affected subjective assessment of performance.

Effect of iron deficiency on tissue oxygen delivery in cyanotic congenital heart disease.

To test the hypothesis that tissue oxygen delivery would be affected by diminished oxygen stores in cyanotic congenital heart disease, serum ferritin, transferrin saturation, hemoglobin, red cell mean corpuscular volume (MCV), red cell 2,3-diphosphoglycerate (DPG), P50, blood gases, oxygen saturations and systemic oxygen transport were measured in 29 hypoxemic infants and children. For the group, aortic saturation was 81 +/- 9%, PaO2 was 50 +/- 12 mm Hg, hemoglobin 16.2 +/- 2.1 gm/dl and systemic oxygen transport 620 +/- 145 ml/min/m2. P50 was increased above normal values (28.8 +/- 2.3 vs 26.6 +/- 1.1 mm Hg, p less than 0.01), and DPG was 2.35 +/- 0.54 mumol/ml, at the upper limits of normal for this assay. Iron deficiency was present in 8. When patients with P50 greater than or equal to 30 mm Hg and P50 less than 30 mm Hg were compared, iron stores were diminished in the high P50 group: [serum ferritin (19 +/- 8 vs 53 +/- 48 ng/ml, p = 0.0006), transferrin saturation (11 +/- 6 vs 23 +/- 11%, p = 0.003) and MCV (79 +/- 8 vs 86 +/- 4 fl, p = 0.05)]. Hemoglobin, aortic oxygen saturation, PaO2 and systemic oxygen transport were similar in both groups. In children with iron sufficiency, 15 of 21 had MCV greater than 90th percentile for age and sex (p less than 0.001 versus expected distribution). Also, MCV greater than 90th percentile for age and sex had a positive predictive value of 0.88 for iron sufficiency. This study demonstrates that diminished iron stores in cyanotic congenital heart disease are associated with a more right-shifted oxyhemoglobin dissociation curve (increased P50).(ABSTRACT TRUNCATED AT 250 WORDS)

Interaction of iron deficiency and lead and the hematologic findings in children with severe lead poisoning.

Microcytic anemia, long considered an effect of lead poisoning, may in fact result from coexisting iron deficiency. In this study, how RBC size, hemoglobin, and zinc protoporphyrin vary as a function of iron status in a group of children with high lead levels was examined. Charts of all children (N = 51) admitted to Cook County Hospital for treatment of lead poisoning in 1981 to 1983 were reviewed for data on age, blood lead level, hemoglobin concentration, MCV, transferrin saturation and zinc protoporphyrin level. The mean lead level was 86 micrograms/dL and the range was 63 to 190 micrograms/dL. Children with transferrin saturation values less than 7% had a mean MCV of 56 microL, hemoglobin of 8.9 g/dL, and zinc protoporphyrin of 693 micrograms/dL; for those with saturations of 7% to 16%, the values were 61 microL, 10.1 g/dL, and 581 micrograms/dL, respectively; the children with saturations greater than 16% had normal mean MCVs and hemoglobin concentrations (74 microL and 11.4 g/dL) and a mean zinc protoporphyrin value of 240 micrograms/dL (P less than .0005). Multiple linear regression was used to correct for effect of age, and transferrin saturation remained the most important predictor of MCV, hemoglobin, and zinc protoporphyrin levels; the addition of lead did not improve the models. Results of this study suggest that iron deficiency is strongly associated with some of the observed toxicities of lead. Also, lead poisoning can exist without producing microcytosis or anemia, and zinc protoporphyrin concentration may not be a sensitive indicator of lead level in the absence of iron deficiency.

Sweat iron loss of male and female runners during exercise.

Male (n = 9) and female (n = 8) collegiate cross-country runners were studied during a training session to determine the amount of iron lost in the sweat. Sweat samples were collected from the arm using polyethylene bags. Total sweat loss was determined by weighing subjects before and after the runs. Average time of sweat collection was 42 min for males and 39 min for females. Sweat rate for the males (717.5 +/- 145.9 g/m2/h) was significantly greater than for the females (460.1 +/- 142.9 g/m2/h); however, the sweat rate per km was not significantly different. Females had a significantly greater sweat iron concentration (0.417 +/- 0.024 mg/l) than males (0.179 +/- 0.011 mg/l). Rate of sweat iron loss was not significantly different for females (0.276 +/- 0.140 mg/h) and males (0.21 +/- 0.13 mg/h). Sweat iron concentration was inversely related with sweat rate (r = -0.64). Our data suggest that although males lose more total sweat than females, the higher sweat iron concentration of females leads to similar rates of iron loss. For female runners, sweat iron loss coupled with a low dietary iron intake may result in a negative iron balance.

Reservas hepáticas de hierro y nivels de perritina en suero de pacientes alcohólicos y no alcohólicos con hepatopatias crónicas / Hepatic iron stores and serum ferritin levels in alcoholic and non-alcoholic patients with chronic liver diseases

Con el objeto de evaluar la utilidad de la ferritina en suero (Ft) como indicador de reservas de hierro de pacientes alcohólicos y no alcohólicos con hepatopatías clínicas se estudiaron 35 pacientes: 18 con cirrosis o fibrosis alcohólica y 17 con padecimientos hepáticos de etiología diversa, no alcohólicos. Los pacientes alcohólicos tenían 3 a 32 meses de abstinencia alcohólica. Las reservas de hierro se establecieron mediante la cuantificación de hierro no hemínico (HNH) en biopsia hepática. En 8 casos del grupo de alcohólicos (44%) y en 4 de los no alcohólicos (23%) el HNH estuvo por arriba de muestras cifras de referencia (> 48 mg/100 g en varones y > 20 mg/100 g en mujeres). En los pacientes alcohólicos se obtuvieron correlaciones directas significativas entre Ft y ALAT y Ft vs, bilirrubina total, mientras que estas correlaciones inversas y no significativas en los no alcohólicos. La correlación entre HNH y Ft fue estadísticamente significativa en los no alcohólicos (r = 0.667), pero fu más baja en los alcohólicos (r = 0.478). Concluimos que: a) la siderosis hepática, descrita en una proporción considerable de los bebedores activos, permanece en los alcohólicos que tienen 3 o más meses de abstinencia alcohólica, b) en individuos con hepatopatías crónicas no alcohólicos la Ft aparentemente sí refleja reservas de hierro, c) en los alcohólicos la inflamación o necrosis hepática modifica los niveles de Ft, por lo tanto este parámetro no es útil para establecer las reservas de hierro en estos pacientes

[Nutritional status of patients with digestive system cancer: preoperative prognostic significance]. / Etat nutritionnel des malades atteints d'un cancer digestif: valeur pronostique pré-opératoire.

We have attempted to establish a prognostic nutritional index prospectively in 633 patients with digestive carcinoma making it possible to predict tumor resectability and occurrence of postoperative complications. The following factors were studied prior to surgery: age, sex, weight loss index, triceps skinfold thickness, midarm circumference, lymphocyte count, plasma albumin, transferrin and prealbumin levels, delayed hypersensitivity as investigated by 8 skin tests. The prognostic nutritional index was calculated using Mullen's formula. Unidimensional and multidimensional studies (linear discriminant and logistic discriminant analyses with partial correlations) were used for the statistical analysis. Mortality was 6,7 p. 100 while 16,2 p. 100 of patients presented a postoperative complication. The following variables showed a significant correlation with the resectability of the tumour: weight loss (p less than 0.0001), triceps skinfold thickness (p less than 0.01), midarm circumference (p less than 0.01), total lymphocyte count (p less than 0.01), plasma transferrin (p less than 0.01), delayed hypersensitivity (p less than 0.05). In the occurrence of postoperative complications there was a statistically significant value only to weight loss (p less than 0.001) and delayed hypersensitivity (p less than 0.05). Logistic discriminant analysis gave a linear model predicting tumor resectability in 78 p. 100 of patients and postoperative complications in 86 p. 100 of patients in which weight loss and delayed hypersensitivity were statistically significant. No prognostic value of Mullen's index was found. This study shows that assessment of the preoperative nutritional status of patients with gastrointestinal cancer makes it possible to predict tumor resectability and postoperative complications.

Screening test for iron overload.

It is presently estimated that 2-3/10(3) people living in the United States are homozygous for the iron-loading gene and are thereby susceptible to severe iron overload. The complications of this disorder can be prevented if recognized in the asymptomatic precirrhotic stage. We have developed a simple, inexpensive screening method for its early laboratory detection based on the fact that one of the earliest laboratory manifestations of hemochromatosis is a reduction in unsaturated iron-binding capacity. The sequential addition of a small measured quantity of saturating iron and bathophenanthroline disulfonate will result in color with highly saturated but not with normal sera. This screening test almost completely differentiated between 40 normal individuals and 40 patients with iron overload (as defined by a transferrin saturation greater than 55%). The test provides a cost-effective method for screening large segments of the population to detect this genetic disorder.

Lack of hepatic transferrin receptor expression in hemochromatosis.

The major part of hepatocellular iron is derived from uptake of transferrin-bound iron by means of nonspecific fluid-phase endocytosis and specific, saturable binding on high-affinity transferrin receptors. We investigated the expression of transferrin receptors on hepatocytes in liver biopsies of 22 cases of hemochromatosis (21 primary hemochromatosis and 1 secondary hemochromatosis), using immunohistochemical demonstration of the human transferrin receptor with the specific monoclonal antibody OKT9. Fifty liver biopsies (normal and pathological) without demonstrable iron storage (Perls' stain negative) served as controls. In the controls, membranous and/or cytoplasmic transferrin receptor expression was always present on hepatocytes, albeit in variable numbers and patterns without obvious relation to the underlying liver disease. In 19 of 22 hemochromatosis cases with severe iron overload, OKT9 immunoreactivity on hepatocytes was completely absent. Three hemochromatosis cases showed few hepatocytes positive for OKT9. One showed mild iron overload, while the second, a successfully treated case, was free of iron. The remaining hemochromatosis case was a known alcoholic with severe iron overload. Since OKT9 binding to the transferrin receptor is not blocked by previous binding of transferrin, the findings show that in advanced hemochromatosis hepatocytes do not express transferrin receptors. This finding is in keeping with the inverse relation between transferrin receptor expression and exogenous iron supply in various cell cultures. These results indicate that in hemochromatosis,apparently as a result of progressive iron overload,transferrin receptor expression on hepatocytes disappears.(ABSTRACT TRUNCATED AT 250 WORDS)